Analysts at StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “sell” rating on the medical equipment provider’s stock.
Aethlon Medical Stock Performance
AEMD stock opened at $0.40 on Friday. The company’s 50-day simple moving average is $0.39 and its 200 day simple moving average is $0.53. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $2.35. The company has a market capitalization of $5.62 million, a PE ratio of -0.11 and a beta of 1.74.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.44) by $0.10. During the same quarter last year, the company earned ($1.30) earnings per share. On average, analysts forecast that Aethlon Medical will post -1.1 EPS for the current year.
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Read More
- Five stocks we like better than Aethlon Medical
- Profitably Trade Stocks at 52-Week Highs
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Invest in the Best Canadian Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- The Significance of Brokerage Rankings in Stock Selection
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
